SCHEMBL12066439

SCHEMBL12066439

CC(N)C(=O)N1CCC[C@H]1c1ncc(-c2ccc(C#Cc3ccc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](Nc5cccnc5)C(C)C)[nH]4)cc3)cc2)[nH]1

nearest known ligand 0.57

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.57
CYP2C9 P11712 3/20 0.57
NR1I2 O75469 2/20 0.57
KCNH2 Q12809 2/20 0.57
ABCB11 O95342 1/20 0.57
OPRK1 P41145 1/20 0.57
CYP1A2 P05177 2/20 0.52
CYP2D6 P10635 1/20 0.51
OPRM1 P35372 2/20 0.43
OPRD1 P41143 2/20 0.43
HCRTR1 O43613 1/20 0.41
HCRTR2 O43614 1/20 0.41
PRCP P42785 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10145515 0.91 CYP3A4 (0.72) CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL12159463 0.88 CYP3A4 (0.65) CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL12159461 0.88 CYP3A4 (0.64) CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL12159462 0.88 CYP3A4 (0.64) CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL13560543 0.87 CYP3A4 (0.61) CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL3342008 0.86 CYP3A4 (0.67) CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL18171398 0.85 CYP3A4 (0.61) CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL14479477 0.85 CYP3A4 (0.80) CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL3347722 0.85 CYP3A4 (0.62) CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL2587330 0.84 CYP3A4 (0.59) CYP3A4CYP2C9NR1I2KCNH2ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011150243-A1 INHIBITORS OF HCV NS5A PRESIDIO PHARMACEUTICALS, INC. (US) 2011-12-01 WO disclosed